The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multi-center, single arm phase II study of the dual mTORC1/mTORC2 inhibitor vistusertib for patients with recurrent or progressive grade II-III meningiomas.
 
Scott Randall Plotkin
Stock and Other Ownership Interests - NF2 Therapeutics; NFlection Therapeutics; SonaCare Medical
Consulting or Advisory Role - Akouos; AstraZeneca; NFlection Therapeutics; SonaCare Medical
Research Funding - AstraZeneca; Pfizer; Takeda (Inst)
Travel, Accommodations, Expenses - NFlection Therapeutics
(OPTIONAL) Uncompensated Relationships - Pfizer (Inst)
 
Priya Kumthekar
Stock and Other Ownership Interests - Vivacitas Oncology
Consulting or Advisory Role - Biocept; Biocept; ElevateBio; Janssen; Novocure; Orbus Therapeutics
Research Funding - Angiochem; DNAtrix; Genentech; Novocure; Orbus Therapeutics
Patents, Royalties, Other Intellectual Property - Utility patent for ANG 1005. No financial gain, no royalties.
 
Patrick Y. Wen
Consulting or Advisory Role - Agios; AstraZeneca; Bayer; Blue Earth Diagnostics; deciphera; Deciphera; ElevateBio; Immunomic Therapeutics; Imvax; Integral Health; Karyopharm Therapeutics; KIYATEC; Puma Biotechnology; QED Therapeutics; Taiho Pharmaceutical; Taiho Pharmaceutical; Tocagen; Vascular Biogenics; VBI Vaccines; Voyager Therapeutics
Speakers' Bureau - Merck; Prime Oncology
Research Funding - Abbvie (Inst); Agios (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Beigene (Inst); Celgene (Inst); Kazia Therapeutics (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Novartis (Inst); Oncoceutics (Inst); Puma Biotechnology (Inst); Vascular Biogenics (Inst); VBI Vaccines (Inst)
 
Frederick G. Barker
No Relationships to Disclose
 
Anat Stemmer-Rachamimov
No Relationships to Disclose
 
Roberta L. Beauchamp
No Relationships to Disclose
 
Justin T Jordan
Stock and Other Ownership Interests - Navio Theragnostics
Consulting or Advisory Role - CereXis; ClearView Healthcare Partners; Gerson Lehrman Group; Guidepoint Global; Health2047; Navio Theragnostics; Recursion Pharmaceuticals
Patents, Royalties, Other Intellectual Property - textbook royalties
Expert Testimony - Medical Mutual Insurance Company of Maine
Other Relationship - American Academy of Neurology (AAN); Neurofibromatosis Network; Shepherd Foundation; Shepherd Therapeutics
 
Alona Muzikansky
Consulting or Advisory Role - Sofregen
 
Vijaya Ramesh
Research Funding - BridgeBio Pharma